Special Feature

User Panel

My Panel

My Panel

Bookmark Science Articles

Recent News
Bookmark / Share This Science Site

Oral administration of a fusion protein containing eight GLP-1 analogues produced in Escherichia coli BL21(DE3) in streptozotocin-induced diabetic rats.

Oral administration of a fusion protein containing eight GLP-1 analogues produced in Escherichia coli BL21(DE3) in streptozotocin-induced diabetic rats. Research Abstract Details 

Research Abstract Table of Contents

Jump to the:

  • Abstract Text of This Paper
  • Journal Published
  • MeSH Keywords of This Abstract
  • Chemicals and Substances Used in this Paper
  • Grants and Granting Agency of this Research
  • Database Accession Numbers Used in this Paper
  • Related Papers
  • Related Research Tags
  • Rate this Research Paper
  • Oral administration of a fusion protein containing eight GLP-1 analogues produced in Escherichia coli BL21(DE3) in streptozotocin-induced diabetic rats. Abstract Text:

    jianhua houJianhua Hou,ruixiang yanRuixiang Yan,dongfeng dingDongfeng Ding,liquan yangLiquan Yang,cuiyan wangCuiyan Wang,zhiqiang wuZhiqiang Wu,xiaoju yuXiaoju Yu,weidong liWeidong Li,minggang liMinggang Li,jianhua houJianhua Hou,ruixiang yanRuixiang Yan,dongfeng dingDongfeng Ding,liquan yangLiquan Yang,cuiyan wangCuiyan Wang,zhiqiang wuZhiqiang Wu,xiaoju yuXiaoju Yu,weidong liWeidong Li,minggang liMinggang Li,

    Glucagon-like peptide-1 (7-36) amide (GLP-1), a gut hormone released into the blood stream after feeding, can stimulate insulin secretion by potentiating the insulinotropic action of glucose. An expression vector pET-22bG8, encoding a fusion protein containing eight tandem repeat GLP-1 ([Ser(8), Gln(26), Asp(34)]-GLP-1) analogues, was constructed and transformed into the Escherichia coli BL21(DE3) strain over-expressing the His-tagged fusion protein under the IPTG promoter. SDS-PAGE and Western blot analysis demonstrated that the His-tagged GLP-1 fusion protein migrated as a single protein with a molecular weight of 32 kDa. Following chronic (10 days) oral administration (20 mg kg(-1) day(-1)) of the fusion protein to diabetic rats, serum glucose levels were significantly lowered from 26 +/- 2.5 to 7.9 +/- 1.4 mmol/l. Further studies are needed to evaluate the potential use for GLP-1 analogue short peptide in the treatment of diabetes mellitus.

    Oral administration of a fusion protein containing eight GLP-1 analogues produced in Escherichia coli BL21(DE3) in streptozotocin-induced diabetic rats. Publishing Authors By Initials

    j houJ Hou,r yanR Yan,d dingD Ding,l yangL Yang,c wangC Wang,z wuZ Wu,x yuX Yu,w liW Li,m liM Li,j houJ Hou,r yanR Yan,d dingD Ding,l yangL Yang,c wangC Wang,z wuZ Wu,x yuX Yu,w liW Li,m liM Li,

    For similar abstracts research abstracts see: abstracts research

    PUBMED ID PMID:

    MEDLINE DATE:

    Oral administration of a fusion protein containing eight GLP-1 analogues produced in Escherichia coli BL21(DE3) in streptozotocin-induced diabetic rats. Journal Published:

    PUBLICATION TYPE: Research Support, Non-U.S. Gov

    Journal: Biotechnology letters

    VOLUME: 29

    Page Numbers: 1439-46

    Journal Abbreviation: Biotechnol. Lett.

    ISSN: 0141-5492

    DAY: 21

    MONTH: 06

    YEAR: 2007

    Oral administration of a fusion protein containing eight GLP-1 analogues produced in Escherichia coli BL21(DE3) in streptozotocin-induced diabetic rats. Information

    Number of References:

    LANGUAGE: eng

    NlmUniqueID: 8008051

    Oral administration of a fusion protein containing eight GLP-1 analogues produced in Escherichia coli BL21(DE3) in streptozotocin-induced diabetic rats. Keywords Mesh Terms:

    KEYWORDS:

    MESH TERMS:

    Chemical & Substance for Abstract: Oral administration of a fusion protein containing eight GLP-1 analogues produced in Escherichia coli BL21(DE3) in streptozotocin-induced diabetic rats. Information

    Substance Name:

    Registry Number:

    Grant and Affiliation Information for Oral administration of a fusion protein containing eight GLP-1 analogues produced in Escherichia coli BL21(DE3) in streptozotocin-induced diabetic rats.

    AFFILIATION: The Key Laboratory for Bioactivematerial of Ministry of Education, Institute for Molecular Biology, College of Life Science, Nankai University, Tianjin, 300071, P.R. China.

    Country: Netherlands

    Netherlands Research PublicationNetherlands Research Publication

    AGENCY:

    GRANT:

    ACRONYM:

    MEDLINETA: Biotechnol Lett

    REFSOURCE:

    DATABASENAME:

    ACCESSION NUMBER:

    Number Hits: 0

    Oral administration of a fusion protein containing eight GLP-1 analogues produced in Escherichia coli BL21DE3 in streptozotocin-induced diabetic rats Related Publications

     

    Molecular Station USER Menu

    Welcome to Molecular Station!

    You have to register before you can post on our forums or use our advanced features. Register Now! Its Free and Fast!

    Already registered? Login now below.

    User Name:

    Password:

    Already registered and Forgot your password? Click below to recover it.

    Recover Lost Password

    Join now - it's fast and free!

    Molecular Station is THE largest network of researchers, scientists and science lovers anywhere!

    Research Terms of Usage and Disclaimer
    Home
    Features

    Protocols

    DNA Forum

    Science Forum

    DNA Forum
    Biology Forum

    Science News


    [CaRP] XML error: Invalid document end at line 2

    For more click here:Science News